Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course

分子真菌学:真菌发病机制的最新方法 (MoMy) 培训课程

基本信息

  • 批准号:
    10461947
  • 负责人:
  • 金额:
    $ 10.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-04 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The purpose of this application is to support the Molecular Mycology and Pathogenesis education program (MOMY) at the Marine Biological Laboratory (MBL) in Woods Hole, MA. MOMY is now approaching its 25th anniversary at the MBL. Over the course’s history it has provided pivotal training for a scientific workforce to meet the world’s biomedical research needs related to the growing incidence of, and limited therapeutic options for, human fungal infections. Simply put, there is an urgent need for new research with human fungal infections given the rapid advances in immune modulating medical therapies that often result in opportunistic fungal infections. MOMY has addressed both the significant impact of fungi on morbidity and mortality in immune compromised patient populations, as well as the role of fungi as microbiome components that affect health and disease. Our intensive and immersive MOMY program provides trainees hands-on laboratory skill training by leading scientists in the fields of fungal biology, immunology & host response, and antifungal drug development. These skills are critical to develop and promote a well-trained workforce in the face of the growing threat posed by fungi to human well-being. MOMY’s objective during the 2 week course is to provide foundational knowledge and training in the techniques, procedures, and concepts in molecular mycology through direct experiences working with fungi and animal models of fungal disease. Importantly, MOMY provides critical career mentoring and professional development opportunities throughout the course to all participants. We achieve our objective in part through the participation of a diverse and committed faculty who are leading experts from the mycology community. Our specifics aims are: (1) To provide in-depth instruction on fundamental contemporary skills in molecular medical mycology; (2) To provide mentored research opportunities based on cutting edge methods and concepts in molecular medical mycology; and (3) To provide trainees with career mentoring, including professional development advice, science ethics training, and development of a lifelong professional mentoring network. Overall, MOMY has a long history of successfully meeting these aims to advance the NIH Mission and advance our ability to ask, explore, and answer critical questions related to the impact of fungi on human health. The course remains of utmost significance given the increasing scope and incidence of fungi’s impact on humanity and the rapid research technological and conceptual advances occurring in our field.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David R Andes其他文献

David R Andes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David R Andes', 18)}}的其他基金

Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
基于共生的涡轮霉素的发现,这是一种针对耐药真菌的安全且选择性的抗真菌药物
  • 批准号:
    10584574
  • 财政年份:
    2022
  • 资助金额:
    $ 10.81万
  • 项目类别:
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
基于共生的涡轮霉素的发现,这是一种针对耐药真菌的安全且选择性的抗真菌药物
  • 批准号:
    10414553
  • 财政年份:
    2022
  • 资助金额:
    $ 10.81万
  • 项目类别:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
分子真菌学:真菌发病机制的最新方法 (MoMy) 培训课程
  • 批准号:
    10313447
  • 财政年份:
    2021
  • 资助金额:
    $ 10.81万
  • 项目类别:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
分子真菌学:真菌发病机制的最新方法 (MoMy) 培训课程
  • 批准号:
    10664997
  • 财政年份:
    2021
  • 资助金额:
    $ 10.81万
  • 项目类别:
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
针对动物微生物共生体中的耐多药病原体的新型抗菌药物
  • 批准号:
    10376275
  • 财政年份:
    2019
  • 资助金额:
    $ 10.81万
  • 项目类别:
In vivo Core
体内核心
  • 批准号:
    10592383
  • 财政年份:
    2019
  • 资助金额:
    $ 10.81万
  • 项目类别:
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
针对动物微生物共生体中的耐多药病原体的新型抗菌药物
  • 批准号:
    10592380
  • 财政年份:
    2019
  • 资助金额:
    $ 10.81万
  • 项目类别:
In vivo Core
体内核心
  • 批准号:
    10571216
  • 财政年份:
    2019
  • 资助金额:
    $ 10.81万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10592381
  • 财政年份:
    2019
  • 资助金额:
    $ 10.81万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10571214
  • 财政年份:
    2019
  • 资助金额:
    $ 10.81万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.81万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了